1. Regarding combination therapies for the treatment of acute migraine headaches, identify the false statement.

• Monotherapy with triptans does not result in rapid, consistent, and complete relief of migraine in all patients.
• In patients suffering from migraine headaches with auras, triptans are not effective when administered while the patient has an aura.
• With the use of ergotamine combinations, there is a higher incidence of nausea than triptans but less headache recurrence.
• The average oral dose of ergotamine is 4 mg.

2. A 43-year-old patient with a history of IHD, PAD and T2DM presents with an acute migraine headache. Which of the following drugs used for acute therapy is the best choice for this patient?

• Sumatriptan
• Rizatriptan
• Ergotamine
• Lasmiditan

3. You are considering preventative therapeutic options for a 33-year-old patient with migraine headaches. From the listed therapeutic agents, select one that is not used for this purpose.

• Flunarizine
• Topiramate
• Melatonin
• Fluoxetine

4. When considering the options for migraine preventative therapy in a patient with a medical history significant for asthma, which of the following medications are contraindicated?

• Propranolol
• Metoprolol
• Amitryptiline
• Pizotifen

5. Drug-induced Parkinsonism can develop with the use of which of these agents as a migraine preventative medication?

• Topiramate
• Valproate
• Nortriptyline
• Flunarizine